TITLE

Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes

AUTHOR(S)
Moisseiev, Elad; Waisbourd, Michael; Ben-Artsi, Elad; Levinger, Eliya; Barak, Adiel; Daniels, Tad; Csaky, Karl; Loewenstein, Anat; Barequet, Irina
PUB. DATE
February 2014
SOURCE
Graefe's Archive of Clinical & Experimental Ophthalmology;Feb2014, Vol. 252 Issue 2, p331
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Topical bevacizumab is a potential treatment modality for corneal neovascularization, and several recent studies have demonstrated its efficacy. No previous study of the pharmacokinetics of topical bevacizumab has been performed in human eyes. The purpose of this study is to investigate the pharmacokinetics of topical administration of bevacizumab in human eyes, and also to compare the pharmacokinetics of intravitreal bevacizumab injections with previously reported data. Methods: Twenty-two (22 eyes) were included in this study, and divided into four groups: eight patients received topical bevacizumab and aqueous samples were obtained 1 hour later during cataract extraction surgery (group 1), eight patients received topical bevacizumab and vitreous samples were obtained 1 day later during pars-plana vitrectomy (PPV) (group 2), three patients received intravitreal bevacizumab and vitreous samples were obtained during PPV (group 3). Vitreous samples from three patients who received no bevacizumab served as controls (group 4). All samples underwent enzyme-linked immunosorbent assay to detect bevacizumab. Results: No bevacizumab was detected in the aqueous or vitreous of any topically treated eyes. The mean vitreal half-life for intravitreally injected bevacizumab was 4.9 days in four non-vitrectomized eyes and 0.66 days in one previously vitrectomized eye. Conclusions: Topically administered bevacizumab does not penetrate the cornea into the anterior chamber and vitreous cavity, indicating that topical use for treating corneal neovascularization has minimal risk of intraocular penetration and adverse events related to intraocular vascular endothelial growth factor inhibition. The half-life following intravitreal bevacizumab injection measured in this study is comparable to that of previous reports, and includes the first demonstration of a significantly reduced half-life following intravitreal injection in a previously vitrectomized eye.
ACCESSION #
94255268

 

Related Articles

  • Efficacy of Primate Humoral Passive Transfer in a Murine Model of Pneumonic Plague Is Mouse Strain-Dependent. Graham, V. A.; Hatch, G. J.; Bewley, K. R.; Steeds, K.; Lansley, A.; Bate, S. R.; Funnell, S. G. P. // Journal of Immunology Research;2014, p1 

    New vaccines against bio defense-related and emerging pathogens are being prepared for licensure using the US Federal Drug Administration's "Animal Rule." This allows licensure of drugs and vaccines using protection data generated in animal models. A new acellular plague vaccine composed of two...

  • Vascular Endothelial Growth Factor in Aqueous Humor of Patients with Perforative Eye Injuries. Merlak, Maja; Kovačević, Damir; Balog, Tihomir; Marotti, Tanja; Lenac, Renata Gržetić; Romac, Ivana; Dekaris, Iva // Collegium Antropologicum;Oct2008 Supplement 2, Vol. 32, p33 

    Considering that VEGF is the key factor for angiogenesis stimulation, we wanted to establish if VEGF level is increased in aqueous humor of patients with open globe eye injury. The study included 20 patients with open globe injury. During the surgery, aqueous humor samples were taken out and...

  • Role of IL-8 induced angiogenesis in uveal melanoma. Lattanzio, Laura; Tonissi, Federica; Torta, Ilaria; Gianello, Luca; Russi, Elvio; Milano, Gerard; Merlano, Marco; Lo Nigro, Cristiana // Investigational New Drugs;Oct2013, Vol. 31 Issue 5, p1107 

    Introduction Uveal melanoma (UM) is a highly vascularised tumour generally treated with radiotherapy (RT). A recent preclinical study from our group [] demonstrated that RT-associated anti-angiogenic therapy has more than additive effects on cell growth, by modulating vascular endothelial growth...

  • Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Kyoung Soo Kim; Hyun Mi Choi; Yeon-Ah Lee; In Ah Choi; Sang-Hoon Lee; Seung-Jae Hong; Hyung-In Yang; Myung Chul Yoo // Rheumatology International;Apr2011, Vol. 31 Issue 4, p543 

    This study was performed to provide evidence, albeit indirectly, as to which matrix metalloproteinases (MMPs), among the gelatinases MMP-2 and MMP-9 and the collagenases MMP-1 and MMP-13, play a more proactive role in the angiogenic process in arthritic joint. Joint fluid was collected from 33...

  • G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective. Faulkner, L.B.; Tucci, F.; Tamburini, A.; Tintori, V.; Lippi, A.A.; Bambi, F.; Malentacca, F.; Azzari, C.; Gelli, A.M.G.; Genovese, F.; Bernini, G. // Bone Marrow Transplantation;6/1/98, Vol. 21 Issue 11, p1091 

    The optimal dosing schedule of G-CSF for peripheral blood progenitor cell (PBPC) mobilization is still under investigation although many centers use 10 μg/kg/day in a single subcutaneous dose. However, G-CSF clearance increases with increasing absolute neutrophil count (ANC). Hence a G-CSF...

  • A sensitive indirect competitive enzyme-linked immunosorbent assay for the detection of sarsasapogenin in rat plasma. Jing WANG; Ji-hua LIU; Xu GUO; Jian ZHANG; Bo-yang YU // Acta Pharmacologica Sinica;Aug2010, Vol. 31 Issue 8, p984 

    AbstractAim:To generate a polyclonal antibody against sarsasapogenin and to develop an indirect competitive enzyme-linked immunosorbent assay (IC-ELISA) method for the pharmacokinetic study of Sarsasapogenin in rats.Methods:The antigen of sarsasapogenin was produced using an active ester method...

  • Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy. di Lauro, Raffaello; de Ruggiero, Pio; di Lauro, Raffaella; di Lauro, Maria Teresa; Romano, Mario Rosario // Graefe's Archive of Clinical & Experimental Ophthalmology;Jun2010, Vol. 248 Issue 6, p785 

    The purpose of this study is to evaluate the role, the safety and the effectiveness of intravitreal bevacizumab (IVB) injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy (PDR). Case-Control Study Randomized controlled trial performed on 72 eyes...

  • State of the Art for Diagnosis of HIV Infection. Branson, Bernard M. // Clinical Infectious Diseases;12/15/2007 Supplement 4, Vol. 45, pS221 

    Diagnostic tests for human immunodeficiency virus (HIV) infection have undergone considerable evolution since the first enzyme immunoassay (EIA) and Western blot were introduced 2 decades ago. Newer methods detect infection sooner and yield results much faster. Rapid tests represent a major...

  • Determination of Aflatoxin M1 in Milk by ELISA Technique in Mashad (Northeast of Iran). Sani, Ali Mohamadi; Khezri, Mohamad; Moradnia, Halime // ISRN Toxicology;2012, p1 

    The aim of this study was to detect the amount of aflatoxin M1 (AFM1) in pasteurized milk samples in Mashad in northeast of Iran. For this purpose, 42 milk samples were collected from retail stores during fall 2011 and analyzed for AFM1 by enzymelinked immunosorbent assay (ELISA) technique. All...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics